Neurodynamic Interventions for Multiple Sclerosis

October 19, 2018 updated by: César Fernández-de-las-Peñas, Universidad Rey Juan Carlos

Effects of Neurodynamic Interventions to Multimodal Physical Therapy in Patients With Multiple Sclerosis

A randomized, parallel-group, clinical trial will be conducted to compare the immediate effects of the inclusion of a neurodynamic intervention into a multimodal physiotherapy program on pressure pain sensitivity, pain and manual dexterity in patients with multiple sclerosis

Study Overview

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Alcorcon, Madrid, Spain, 28922
        • César Fernández-de-las-Peñas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • a diagnosis of multiple sclerosis according to the modified McDonald criteria;
  • symptoms of paresthesia and lack of sensitivity in the upper extremity;
  • Expanded Disability Status Scale (EDSS) between 0 and 6.5 points;
  • absence of cognitive deficit.

Exclusion Criteria:

  • any exacerbation of multiple sclerosis during the previous 3 months;
  • previous hand surgery or steroid injections treatment in the upper extremity;
  • multiple diagnoses on the upper extremity (e.g., cervical radiculopathy);
  • cervical, shoulder, or upper extremity trauma;
  • other comorbid musculoskeletal medical conditions;
  • mini-mental state examination <25

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Physical Therapy
Patients will receive 5 session of multimodal physiotherapy treatment of 30min duration including low-load strength exercises, soft tissue mobilization and muscle-tendon stretching exercises twice per week.
Patients will receive 5 session of multimodal physiotherapy treatment of 30min duration including low-load strength exercises, soft tissue mobilization and muscle-tendon stretching exercises twice per week.
EXPERIMENTAL: Physical Therapy plus neurodynamic
Patients will receive 5 session of multimodal physiotherapy treatment of 30min duration including low-load strength exercises, soft tissue mobilization and muscle-tendon stretching exercises twice per week. In addition, they will also receive bilateral nerve slider neurodynamic interventions targeting the median, ulnar and radial nerves.
Patients will receive 5 session of multimodal physiotherapy treatment of 30min duration including low-load strength exercises, soft tissue mobilization and muscle-tendon stretching exercises twice per week. In addition, they will also receive bilateral nerve slider neurodynamic interventions targeting the median, ulnar and radial nerves.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in pressure pain sensitivity
Time Frame: Baseline and one week after the last treatment session
Pressure pain threshold over the median, ulnar and radial nerves, second metacarpal and tibialis anterior
Baseline and one week after the last treatment session

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in upper extremity pain intensity before and after the intervention
Time Frame: Baseline and one week after the last treatment session
A Numerical Pain Rate Scale (NPRS, 0-10) will be used to record the mean and the worst intensity of pain in te upper extremity
Baseline and one week after the last treatment session
Changes in light touch detection threshold
Time Frame: Baseline and after treatmentBaseline and one week after the last treatment session
Light touch detection threshold will be assessed with a standardized set of modified twenty von Frey hairs
Baseline and after treatmentBaseline and one week after the last treatment session
Changes in manual dexterity
Time Frame: Baseline and one week after the last treatment session
Bilateral manual dexterity was bilaterally assessed using the nine-hole peg test
Baseline and one week after the last treatment session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 26, 2018

Primary Completion (ACTUAL)

September 15, 2018

Study Completion (ACTUAL)

October 4, 2018

Study Registration Dates

First Submitted

July 2, 2018

First Submitted That Met QC Criteria

July 12, 2018

First Posted (ACTUAL)

July 23, 2018

Study Record Updates

Last Update Posted (ACTUAL)

October 22, 2018

Last Update Submitted That Met QC Criteria

October 19, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe